Literature DB >> 3718785

Kinetics of trabecular bone resorption and formation in hypothyroidism: evidence for a positive balance per remodeling cycle.

E F Eriksen, L Mosekilde, F Melsen.   

Abstract

Using a recently described model for reconstruction of the entire remodeling sequence in trabecular bone after tetracycline double labeling, bone remodeling was investigated in 18 hypothyroid female patients and 11 age- and sex-matched controls. In the hypothyroid group, the final resorption depth was reduced to 42 microns vs 53 microns in the control group (P less than 0.01). The total resorption period was increased to 76 days vs 32 days in the control group (P less than 0.001), and the resorption rate was lowered to 0.8 micron/day vs 2.1 microns/day in the control group (P less than 0.001). The function period for preosteoblast-like cells was 22 days compared to 14 days in normals (P less than 0.05). The total bone formation period was prolonged to 620 days in the hypothyroid group compared to 151 days in the control group (P less than 0.001), and the matrix and mineral appositional rates were lowered to 0.7 and 0.5 micron3/micron2 per day compared to 1.8 (P less than 0.001) and 1.4 (P less than 0.001) micron3/micron2 per day, respectively. The mineralization lag time in the hypothyroid group was 48 days vs 25 days in the control group (P less than 0.001), and at the start of bone formation this difference was even more pronounced (63 and 16 days, respectively, P less than 0.001). The mean completed wall thickness was increased in the hypothyroid group to 59.5 microns compared to 54 micron in the control group (P less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3718785     DOI: 10.1016/8756-3282(86)90681-2

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  20 in total

1.  Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts.

Authors:  J H Duncan Bassett; Alan Boyde; Peter G T Howell; Richard H Bassett; Thomas M Galliford; Marta Archanco; Holly Evans; Michelle A Lawson; Peter Croucher; Donald L St Germain; Valerie Anne Galton; Graham R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

2.  Is prophylactic anti-resorptive therapy required in thyroid cancer patients receiving TSH-suppressive treatment with thyroxine?

Authors:  Graham R Williams
Journal:  J Endocrinol Invest       Date:  2014-06-18       Impact factor: 4.256

Review 3.  Thyroid hormone actions in cartilage and bone.

Authors:  Graham R Williams
Journal:  Eur Thyroid J       Date:  2012-12-19

4.  Biomechanical performance of diaphyseal shafts and bone tissue of femurs from hypothyroid rats.

Authors:  María I Conti; María P Martínez; María I Olivera; Clarisa Bozzini; Patricia Mandalunis; Carlos E Bozzini; Rosa M Alippi
Journal:  Endocrine       Date:  2009-08-11       Impact factor: 3.633

5.  Do bone turnover markers reflect changes in bone microarchitecture during treatment of patients with thyroid dysfunction?

Authors:  C J Vinther; L H Poulsen; P Nicolaisen; M L Obling; T H Brix; A P Hermann; L Hegedüs; N R Jørgensen; S Hansen; S J Bonnema
Journal:  J Endocrinol Invest       Date:  2022-09-05       Impact factor: 5.467

6.  Pharmacokinetic considerations in determining the terminal elimination half-lives of bisphosphonates.

Authors:  Kenneth C Lasseter; Arturo G Porras; Andrew Denker; Anu Santhanagopal; Anastasia Daifotis
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

Review 7.  [Impact of thyroid diseases on bone].

Authors:  E Tsourdi; F Lademann; H Siggelkow
Journal:  Internist (Berl)       Date:  2018-07       Impact factor: 0.743

Review 8.  Role of Thyroid Hormones in Skeletal Development and Bone Maintenance.

Authors:  J H Duncan Bassett; Graham R Williams
Journal:  Endocr Rev       Date:  2016-02-10       Impact factor: 19.871

9.  Central hypothyroidism.

Authors:  Vishal Gupta; Marilyn Lee
Journal:  Indian J Endocrinol Metab       Date:  2011-07

10.  Bone health in children with long-term idiopathic subclinical hypothyroidism.

Authors:  Raffaella Di Mase; Manuela Cerbone; Nicola Improda; Andrea Esposito; Donatella Capalbo; Ciro Mainolfi; Francesca Santamaria; Claudio Pignata; Mariacarolina Salerno
Journal:  Ital J Pediatr       Date:  2012-10-22       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.